Fresenius reported +19% (organic: +7%) higher sales of €8,362m and a slight rise in the gross profit margin (32.1% versus 31.9%) in Q1. EBITDA rose +26% to €1,560m and net profit attributable to shareholders came in at €457m versus €358m.
Despite higher NWC outflow (€-637m after €-550m), operating CF soared by +42% to €476m. The balance sheet reported a massive step up in receivables and a moderate rise in inventories. Investing CF (€-5,796m after €-530m) reflected the payment of the purchase ....
03 May 2017
Quirónsalud’s first ‘Hello’
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Quirónsalud’s first ‘Hello’
Fresenius SE & Co. KGaA (FRE:WBO) | 0 0 0.5% | Mkt Cap: 35,173m
- Published:
03 May 2017 -
Author:
Martin Schnee -
Pages:
3
Fresenius reported +19% (organic: +7%) higher sales of €8,362m and a slight rise in the gross profit margin (32.1% versus 31.9%) in Q1. EBITDA rose +26% to €1,560m and net profit attributable to shareholders came in at €457m versus €358m.
Despite higher NWC outflow (€-637m after €-550m), operating CF soared by +42% to €476m. The balance sheet reported a massive step up in receivables and a moderate rise in inventories. Investing CF (€-5,796m after €-530m) reflected the payment of the purchase ....